Search Results - "Proskurin, M.A."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2
  3. 3

    BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by Kolbin, A.S., Vilyum, I.A., Proskurin, M.A., Balykina, Yu.E.

    Published in Farmakoèkonomika (Moskva. Online) (01-06-2015)
    “…We have performed the first-ever Budget Impact Analysis (BIA) in a Russian context of bendamustine in the first line of therapy of a multiple myeloma for…”
    Get full text
    Journal Article
  4. 4

    PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS by A.S. Kolbin, M.A. Proskurin, Yu.A. Balykina, N.N. Klimko

    “…Invasive candidiasis is a common cause of neonatal sepsis, especially in children with very low birth weight. This study, for the first time in the world of…”
    Get full text
    Journal Article
  5. 5

    PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS by A.S. Kolbin, M.A. Proskurin, Yu.A. Balykina, N.N. Klimko

    “…Invasive candidiasis is a common cause of neonatal sepsis, especially in children with very low birth weight. This study, for the first time in the world of…”
    Get full text
    Journal Article